Embolism and Thrombosis: all 53 studies

Page 1 of 1. Open to participants first (11), then studies with results posted, then the rest; newest registration first within each.

• The ReCAna for Lower ExtremIty Venous OBstructions and In-StEnt Restenosis RegistryNot yet recruitingNCT07529756
• STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients Without an Indication for Oral AnticoagulantRecruitingNCT07007143Phase 4
• STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for Oral AnticoagulantRecruitingNCT06901466Phase 4
• Natural History of Isolated Calf Vein Thrombosis - A Prospective Cohort Under Ultrasound SurveillanceRecruitingNCT06683157
• Cancer-related Venous Thromboembolic Disease - Cohort StudyRecruitingNCT06393764
• Prolonged Anticoagulation Therapy on the Prognosis of Patients With Left Ventricular ThrombosisNot yet recruitingNCT06209892Not applicable
• Observational Dutch Young Symptomatic StrokE studY - nEXTRecruitingNCT05853796
• Collection of Blood Samples for New Diagnostic Devices 2RecruitingNCT05568966
• Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in Patients With Liver CirrhosisRecruitingNCT04874428Phase 1
• Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary EmbolismRecruitingNCT04263038Phase 4
• Ongoing Registry of Treatment of Venous ThromboembolismRecruitingNCT03881345
• Selective Pulmonary-artery Intervention to Reduce Acute Right-heart tEnsion-ICompletedNCT06571760Not applicableResults posted
• Aventus Thrombectomy System Pulmonary Embolism Clinical StudyActive, not recruitingNCT05907564Not applicableResults posted
• A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip ArthroplastyCompletedNCT01203098Phase 2Results posted
• A Phase 3 Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee ArthroplastyCompletedNCT01181102Phase 3Results posted
• Registry of AngioJet Use in the Peripheral Vascular SystemCompletedNCT01086215Results posted
• Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 InducerCompletedNCT00786422Phase 2Results posted
• Epidemiology of Thromboembolism Disease: A Cohort StudyCompletedNCT00670540Results posted
• Single Center Post-Market Study of Thrombolytic Therapy Using the Versus™ CatheterWithdrawnNCT06975969
• Diffrence in Thromboprofilaksis in Elderly Ostoepenic Hip Fractures According to Mobility Status by Genetic AnalysisActive, not recruitingNCT06959017Not applicable
• Selective Pulmonary-artery Intervention to Reduce Acute Right-heart tEnsion-IICompletedNCT06576427Not applicable
• The Effect of Dexamethasone 12 mg vs 6 mg on Thromboembolic Events in Patients With Critical COVID-19CompletedNCT05195242Phase 3
• A Study to Compare Pharmacokinetic Parameters and Safety Profiles Between AD-109 and AD-1091CompletedNCT05128591Phase 1
• Safety and Efficiency of the YEARS Algorithm Versus Computed Tomography Pulmonary Angiography Alone for Suspected Pulmonary Embolism in Patients With MalignancyCompletedNCT04657120Not applicable
• COVID-19 Registry to Assess Frequency, Risk Factors, Management, and Outcomes of Arterial and Venous Thromboembolic ComplicationsCompletedNCT04535128
• Effectiveness of NextDose for Warfarin Dose IndividualizationStatus unknownNCT04510805Phase 4
• Risk Stratification for Venous Thromboembolism in Hospitalized Medical PatientsCompletedNCT04439383
• Periprocedural Continuation Versus Interruption of Oral Anticoagulant Drugs During Transcatheter Aortic Valve Implantation (POPular PAUSE TAVI)CompletedNCT04437303Phase 4
• COVID-19, bLOod Coagulation and ThrombosisStatus unknownNCT04388657
• Evaluation of the LumiraDx Point of Care D-Dimer and CRP TestsCompletedNCT04375982
• Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19CompletedNCT04368377Phase 2
• Screening for Occult Malignancy in Patients With Unprovoked Venous ThromboembolismActive, not recruitingNCT04304651Not applicable
• Rotterdam EDOXaban Leaflet Evaluation in Patients After Transcatheter Aortic Valve ImplantationStatus unknownNCT04171726Phase 3
• The Portuguese Survey on Anticoagulated Patients Register (START-Portugal-Register)TerminatedNCT03977363
• Assessment of The Effect of Apixaban in AFCompletedNCT03199521
• Traumatic Intracranial Hemorrhage in Users of Oral Antithrombotic DrugsCompletedNCT02996851
• Study to Evaluate Safety, PK and PD of Single and Multiple Ascending Doses of EP-7041 in Healthy SubjectsCompletedNCT02914353Phase 1
• Prevalence and Causes of Preventable and Serious Adverse Drug Reactions Related to the Use of Oral AnticoagulantsCompletedNCT02720328Phase 4
• Study of the Bioaccumulation of Tinzaparin in Renally Impaired Patients When Given at Prophylactic DosesCompletedNCT02719418
• What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2.Status unknownNCT02635230
• Medical Assistance for the Procreation and Risk of Thrombosis.TerminatedNCT02610608
• Comparison of Accidents and Their Circumstances With Oral AnticoagulantsCompletedNCT02376777
• Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve ImplantationCompletedNCT02247128Phase 4
• Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care TherapyCompletedNCT02210819
• Platelet Activity in Vascular Surgery for Thrombosis and BleedingCompletedNCT01897103
• Cost-effectiveness of Genotype Guided Treatment With Antiplatelet Drugs in STEMI Patients: Optimization of Treatment (POPular Genetics)CompletedNCT01761786Phase 4
• Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care TherapyCompletedNCT01619007
• Need for Antepartum Thromboprophylaxis in Pregnant Women With One Prior Episode of Venous Thromboembolism (VTE)Status unknownNCT01357941
• Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Proximal Deep Vein Thrombosis(ODIXa-DVT)CompletedNCT00839163Phase 2
• The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice SettingsCompletedNCT00830570
• A Comparison of Certoparin and Unfractionated Heparin in the Prevention of Thromboembolic Events in Acutely Ill Medical PatientsCompletedNCT00451412Phase 3
• The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein ThrombosisCompletedNCT00216866Phase 2
• Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial)CompletedNCT00119457Phase 2

← Embolism and Thrombosis overview